特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
910940

乱用薬物検査の世界市場:製品、検体、エンドユーザー別の分析と予測 ~2027年

Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product ; Sample Type ; End User and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 155 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
乱用薬物検査の世界市場:製品、検体、エンドユーザー別の分析と予測 ~2027年
出版日: 2019年08月13日
発行: The Insight Partners
ページ情報: 英文 155 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乱用薬物検査市場は、2018年に57億8,371万米ドルと評価され、2019年から2027年にかけては5.7%のCAGRで推移し、2027年までに93億9,317万米ドル規模の市場に成長すると予測されています。

当レポートでは、世界の乱用薬物検査市場を調査し、市場の概要、製品・検体・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 調査レポートのガイダンス
  • 市場区分

第2章 重要点

第3章 調査方法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 市場情勢

  • 市場概要
  • エコシステムの分析
  • PEST分析

第5章 市場力学

  • 市場の成長要因
  • 市場の阻害要因
  • 市場機会
  • 影響分析

第6章 世界の乱用薬物検査市場の分析

  • 収益予測と分析
  • 市場分析と予測:地域別
  • 企業の市場ポジショニング

第7章 世界の乱用薬物検査市場:製品別

  • 概要
  • 市場シェア:製品別(実績値・予測値)
  • 迅速検査装置
  • 分析装置
  • 消耗品

第8章 世界の乱用薬物検査市場:検体別

  • 概要
  • 市場シェア:検体別(実績値・予測値)
  • 血液
  • 尿
  • 唾液
  • その他

第9章 世界の乱用薬物検査市場:エンドユーザー別

  • 概要
  • 市場シェア:エンドユーザー別(実績値・予測値)
  • 病院
  • 診断ラボ
  • 法医学研究所

第10章 世界の乱用薬物検査市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • 中南米

第11章 競合情勢

  • 概要
  • 企業の比較分析
  • 企業の成長戦略
  • 有機開発
  • 無機開発

第12章 企業プロファイル

  • OraSure Technologies, Inc.
  • UCP Biosciences
  • MEDACX Ltd.
  • Beckman Coulter, Inc. (Danaher)
  • Alcolizer Pty Ltd.
  • Wondfo
  • Redwood Toxicology Laboratory (Abbott)
  • F. Hoffmann-La Roche Ltd.
  • Siemens
  • Thermo Fisher Scientific, Inc.
  • Dragerwerk AG & Co. KGaA
  • American Screening Corporation, Inc
  • Mercedes Medical
  • Alfa Scientific Designs, Inc.
  • Express Diagnostics Int'l, Inc.
  • Omega Laboratories, Inc.
  • Laboratorio Sodre

第13章 付録

  • Insight Partnersについて
  • 用語集
図表

LIST OF TABLES

  • Table 1. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 2. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 3. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 4. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 5. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 6. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 7. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 8. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 9. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 10. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 11. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 12. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 13. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 14. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 15. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 16. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 17. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 18. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 19. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 20. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 21. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 22. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 23. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 24. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 25. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 26. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 27. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 28. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 29. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 30. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 31. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 32. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 33. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 34. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 35. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 36. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 37. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 38. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 39. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 40. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 41. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 42. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 43. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 44. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 45. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 46. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 47. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 48. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 49. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 50. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 51. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 52. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 53. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 54. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 55. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 56. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 57. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 58. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 59. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 60. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 61. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 62. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 63. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 64. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 65. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 66. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 67. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 68. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
  • Table 69. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 70. Organic Developments Done By Companies
  • Table 71. Inorganic developments done by Companies
  • Table 72. Glossary of Terms, Drug Abuse Testing Market

LIST OF FIGURES

  • Figure 1. Drug Abuse Testing Market Segmentation
  • Figure 2. Drug Abuse Testing Segmentation, By Region
  • Figure 3. Asia Pacific Drug Abuse Testing Market, Revenue (Us$ Mn), 2018 & 2027
  • Figure 4. Global Drug Abuse Testing Market By Product, Market Share (%), 2018
  • Figure 5. Global Drug Abuse Testing Market By Sample Type, Market Share (%), 2018
  • Figure 6. Global Drug Abuse Testing Market By End User, Market Share (%), 2018
  • Figure 7. North America : PEST Analysis
  • Figure 8. Europe: PEST Analysis
  • Figure 9. Asia - Pacific: PEST Analysis
  • Figure 10. Middle East & Africa: PEST Analysis
  • Figure 11. South & Central America: PEST Analysis
  • Figure 12. Drug Abuse Testing Market Impact Analysis of Driver and Restraints
  • Figure 13. Global Drug Abuse Testing Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 14. Global Drug Abuse Testing Market - By Geography Forecasts And Analysis - 2018- 2027
  • Figure 15. Prominent Players In The Drug Abuse Testing Market
  • Figure 16. Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)
  • Figure 17. Rapid Testing Devices Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 18. Analyzers Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Consumables Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)
  • Figure 21. Blood Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Urine Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Saliva Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. Other Sample Types Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)
  • Figure 26. Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Forensic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. North America Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 30. North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 32. US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 34. Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Europe Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 36. Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 38. UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Asia Pacific Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 44. Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 46. Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 48. India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 50. Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Middle East & Africa Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 52. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 53. Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 54. UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 55. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 56. South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 57. South and Central America Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 58. South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 60. Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 61. Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 62. Comparative Company Analysis
  • Figure 63. Growth Strategies done by the companies in the Market, (%)
目次
Product Code: TIPHE100001303

The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The drug abuse testing market is estimated to grow with a CAGR of 5.7% from 2019-2027.

The market is driven by factors such as, increasing consumption of illicit drugs and laws and regulations related to drug abuse. However, dearth of trained laboratory professionals may limit the growth of the market to a certain extent.

Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S. As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.

Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.

Global drug abuse testing were segmented by product, sample type and end user. The product segment was categorized as rapid testing services, analyzers and consumables. On the basis of sample type, the market is segmented as urine, saliva, blood and others. Based on the end user, the drug abuse testing market is segmented into hospitals, diagnostic laboratories and forensic laboratories.

Some of the major primary and secondary sources included in the report include, Americans with Disabilities Act (ADA), The Australian Health Practitioner Regulation Agency (APHRA), The German Medical Association (BAK), Bureau of Labor Statistics (BLS), Business Monitor International (BMI), Comprehensive Addiction and Recovery Act (CARA), Canadian Drugs and Substances Strategy (CDSS), The Drug Commission of the German Medical Association (DCGMA) and among others.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Drug Abuse Testing Market - By Product
    • 1.3.2 Global Drug Abuse Testing Market - By Sample Type
    • 1.3.3 Global Drug Abuse Testing Market - By End User
    • 1.3.4 Global Drug Abuse Testing Market - By Geography

2. Global Drug Abuse Testing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Drug Abuse Testing Market Landscape

  • 4.1 Overview
  • 4.2 Pest Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Expert Opinion

5. Global Drug Abuse Testing Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Consumption of Illicit Drugs
    • 5.1.2 Laws and Regulations Related to Drug Abuse
  • 5.2 Key Market Restraints
    • 5.2.1 Dearth of Trained Laboratory Professionals
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Adoption of LIMS in Cannabis Testing Laboratories
    • 5.3.2 Advances in Drug Testing Consumables:
  • 5.4 Impact Analysis

6. Drug Abuse Testing Market - Global Analysis

  • 6.1 Global Drug Abuse Testing Market Revenue Forecasts And Analysis
  • 6.2 Global Drug Abuse Testing Market, By Geography - Forecasts And Analysis
  • 6.3 Positioning Of Key Players

7. Global Drug Abuse Testing Market Analysis- by Product

  • 7.1 Overview
  • 7.2 Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)
  • 7.3 Rapid Testing Devices
    • 7.3.1 Overview
    • 7.3.2 Rapid Testing Devices Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Analyzers
    • 7.4.1 Overview
    • 7.4.2 Analyzers Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Consumables
    • 7.5.1 Overview
    • 7.5.2 Consumables Market Revenue and Forecast to 2027 (US$ Mn)

8. Global Drug Abuse Testing Market Analysis- by Sample Type

  • 8.1 Overview
  • 8.2 Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)
  • 8.3 Blood
    • 8.3.1 Overview
    • 8.3.2 Blood Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Urine
    • 8.4.1 Overview
    • 8.4.2 Urine Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.5 Saliva
    • 8.5.1 Overview
    • 8.5.2 Saliva Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.6 Other Sample Types
    • 8.6.1 Overview
    • 8.6.2 Other Sample Types Market Revenue and Forecast to 2027 (US$ Mn)

9. Global Drug Abuse Testing Market Analysis- by End User

  • 9.1 Overview
  • 9.2 Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Forensic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Forensic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10. Drug Abuse Testing Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 10.1 North America Drug Abuse Testing Market Revenue And Forecasts To 2027
    • 10.1.1 North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.1.2 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 10.1.3 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
    • 10.1.4 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.5 North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.1.6 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.6.1 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.6.2 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.1.6.3 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.1.6.4 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.7 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.7.1 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.7.2 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.1.7.3 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.1.7.4 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.8 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.8.1 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.8.2 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.1.8.3 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.1.8.4 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.2 Europe Drug Abuse Testing Market Revenue And Forecasts To 2027
    • 10.2.1 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.2.2 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 10.2.3 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
    • 10.2.4 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.5 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.2.6 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.6.1 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.6.2 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.6.3 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.2.6.4 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.7 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.1 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.2 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.7.3 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.2.7.4 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.8 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.1 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.2 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.8.3 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.2.8.4 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.9 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.1 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.2 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.9.3 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.2.9.4 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.10 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.10.1 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.10.2 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.2.10.3 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.2.10.4 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.3 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027
    • 10.3.1 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.3.2 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 10.3.3 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
    • 10.3.4 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.5 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.3.6 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.6.1 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.6.2 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.3.6.3 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.3.6.4 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.7 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.7.1 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.7.2 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.3.7.3 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.3.7.4 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.8 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.8.1 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.8.2 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.3.8.3 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.3.8.4 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.9 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.9.1 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.9.2 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.3.9.3 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.3.9.4 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.10 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.10.1 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.10.2 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.3.10.3 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.3.10.4 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027
    • 10.4.1 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
    • 10.4.2 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 10.4.3 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
    • 10.4.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.4.5 Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.4.6 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.6.1 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.6.2 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.4.6.3 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)
      • 10.4.6.4 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.4.7 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.7.1 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.7.2 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.4.7.3 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)
      • 10.4.7.4 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.4.8 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.8.1 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.8.2 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.4.8.3 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.4.8.4 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.5 South And Central America Drug Abuse Testing Market Revenue And Forecasts To 2027
    • 10.5.1 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.5.2 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 10.5.3 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
    • 10.5.4 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.5.5 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.5.6 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.6.1 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.6.2 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.5.6.3 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.5.6.4 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.5.7 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.7.1 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.7.2 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.5.7.3 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)
      • 10.5.7.4 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Drug Abuse Testing Market- Industry Landscape

  • 11.1 Overview
  • 11.2 Comparative Company Analysis
  • 11.3 Growth Strategies done by the companies in the Market, (%)
  • 11.4 Organic Developments
    • 11.4.1 Overview
  • 11.5 Inorganic developments
    • 11.5.1 Overview

12. Drug Abuse Testing Market-Key company profiles

  • 12.1 OraSure Technologies, Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 UCP Biosciences
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Overview
    • 12.2.4 Product Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 MEDACX Ltd.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Beckman Coulter, Inc. (Danaher)
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 Product Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Alcolizer Pty Ltd.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 Product Portfolio
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Wondfo
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Financial Overview
    • 12.6.4 Product Portfolio
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Redwood Toxicology Laboratory (Abbott)
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 Product Portfolio
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Financial Overview
    • 12.8.4 Product Portfolio
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Siemens
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Information
    • 12.9.4 Product Portfolio
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Thermo Fisher Scientific, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Financial Information
    • 12.10.4 Product Portfolio
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Dragerwerk AG & Co. KGaA
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Financial Overview
    • 12.11.4 Product Portfolio
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 American Screening Corporation, Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Financial Overview
    • 12.12.4 1.5.4 Product Portfolio
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Mercedes Medical
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Financial Overview
    • 12.13.4 Product Portfolio
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Alfa Scientific Designs, Inc.
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Financial Overview
    • 12.14.4 Product Portfolio
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Express Diagnostics Int'l, Inc.
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Financial Overview
    • 12.15.4 Product Portfolio
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 Omega Laboratories, Inc.
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Financial Overview
    • 12.16.4 Product Portfolio
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Laboratorio Sodre
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Financial Overview
    • 12.17.4 Product Portfolio
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.